Serum C-reactive protein and albumin are useful biomarkers for tight control management of Crohn’s disease in Japan View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2020-01-16

AUTHORS

Hisashi Shiga, Izuru Abe, Motoyuki Onodera, Rintaro Moroi, Masatake Kuroha, Yoshitake Kanazawa, Yoichi Kakuta, Katsuya Endo, Yoshitaka Kinouchi, Atsushi Masamune

ABSTRACT

Tight control management of Crohn’s disease (CD) based on biomarkers is more effective than conventional clinical management; however, fecal calprotectin is not allowed in Asian and some Western countries. To investigate whether tight control management based on readily available serum biomarkers results in better outcomes, we retrospectively reviewed treatment courses of consecutive Japanese CD patients treated with anti-tumor necrosis factor agents between 2003 and 2018. The association between failure of tight control (C-reactive protein (CRP) ≥ 0.5 mg/dL or albumin (Alb) < 3.8 g/dL at week 8 or 24) and subsequent major adverse outcomes (MAOs; hospitalization related to CD worsening, surgery, and discontinuation due to treatment failure) were analyzed. Among 223 patients followed for >8 weeks, 88 patients experienced MAOs. Multivariate analysis identified penetrating type, CRP ≥ 0.5 mg/dL and Alb < 3.8 g/dL at week 8 as independent risk factors (hazard ratios: 2.16, 2.06, and 2.08, respectively). Among 204 patients followed for >24 weeks, 80 patients experienced MAOs. Penetrating type, CRP ≥ 0.5 mg/dL, and Alb < 3.8 g/dL at week 24 were identified as independent risk factors (2.39, 1.90, and 2.20, respectively). Even in settings without fecal calprotectin, tight control management based on serum CRP and Alb may help avoid MAOs. More... »

PAGES

511

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/s41598-020-57508-7

DOI

http://dx.doi.org/10.1038/s41598-020-57508-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1124120242

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/31949246


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adalimumab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "C-Reactive Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Crohn Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hospitalization", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infliximab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Japan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Serum Albumin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Necrosis Factor-alpha", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan", 
          "id": "http://www.grid.ac/institutes/grid.69566.3a", 
          "name": [
            "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shiga", 
        "givenName": "Hisashi", 
        "id": "sg:person.01213707714.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213707714.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan", 
          "id": "http://www.grid.ac/institutes/grid.69566.3a", 
          "name": [
            "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Abe", 
        "givenName": "Izuru", 
        "id": "sg:person.015335735133.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015335735133.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan", 
          "id": "http://www.grid.ac/institutes/grid.69566.3a", 
          "name": [
            "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Onodera", 
        "givenName": "Motoyuki", 
        "id": "sg:person.01177630723.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177630723.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan", 
          "id": "http://www.grid.ac/institutes/grid.69566.3a", 
          "name": [
            "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Moroi", 
        "givenName": "Rintaro", 
        "id": "sg:person.01031346114.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031346114.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan", 
          "id": "http://www.grid.ac/institutes/grid.69566.3a", 
          "name": [
            "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kuroha", 
        "givenName": "Masatake", 
        "id": "sg:person.01001764110.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001764110.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan", 
          "id": "http://www.grid.ac/institutes/grid.69566.3a", 
          "name": [
            "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kanazawa", 
        "givenName": "Yoshitake", 
        "id": "sg:person.0604532214.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604532214.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan", 
          "id": "http://www.grid.ac/institutes/grid.69566.3a", 
          "name": [
            "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kakuta", 
        "givenName": "Yoichi", 
        "id": "sg:person.012611662635.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012611662635.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterology and Hepatology, Tohoku Medical and Pharmaceutical University, Sendai, Japan", 
          "id": "http://www.grid.ac/institutes/grid.412755.0", 
          "name": [
            "Division of Gastroenterology and Hepatology, Tohoku Medical and Pharmaceutical University, Sendai, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Endo", 
        "givenName": "Katsuya", 
        "id": "sg:person.013547252522.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013547252522.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Health Administration Center, Center for the Advancement of Higher Education, Tohoku University, Sendai, Japan", 
          "id": "http://www.grid.ac/institutes/grid.69566.3a", 
          "name": [
            "Health Administration Center, Center for the Advancement of Higher Education, Tohoku University, Sendai, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kinouchi", 
        "givenName": "Yoshitaka", 
        "id": "sg:person.01145574514.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145574514.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan", 
          "id": "http://www.grid.ac/institutes/grid.69566.3a", 
          "name": [
            "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Masamune", 
        "givenName": "Atsushi", 
        "id": "sg:person.01366123207.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366123207.25"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00535-018-1439-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100940665", 
          "https://doi.org/10.1007/s00535-018-1439-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ajg.2015.233", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030438370", 
          "https://doi.org/10.1038/ajg.2015.233"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00535-013-0798-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009680601", 
          "https://doi.org/10.1007/s00535-013-0798-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ajg.2009.545", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029995757", 
          "https://doi.org/10.1038/ajg.2009.545"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1111/j.1572-0241.2007.01556.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027137671", 
          "https://doi.org/10.1111/j.1572-0241.2007.01556.x"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2020-01-16", 
    "datePublishedReg": "2020-01-16", 
    "description": "Tight control management of Crohn\u2019s disease (CD) based on biomarkers is more effective than conventional clinical management; however, fecal calprotectin is not allowed in Asian and some Western countries. To investigate whether tight control management based on readily available serum biomarkers results in better outcomes, we retrospectively reviewed treatment courses of consecutive Japanese CD patients treated with anti-tumor necrosis factor agents between 2003 and 2018. The association between failure of tight control (C-reactive protein (CRP)\u2009\u2265\u20090.5\u2009mg/dL or albumin\u2009(Alb)\u00a0<\u20093.8\u2009g/dL at week 8 or 24) and subsequent major adverse outcomes (MAOs; hospitalization\u00a0related to CD worsening, surgery, and discontinuation due to treatment failure) were analyzed. Among 223 patients followed for >8 weeks, 88 patients experienced MAOs. Multivariate analysis identified penetrating type, CRP\u2009\u2265\u20090.5\u2009mg/dL and Alb\u2009<\u20093.8\u2009g/dL at week 8 as independent risk factors (hazard ratios: 2.16, 2.06, and 2.08, respectively). Among 204 patients followed for >24 weeks, 80 patients experienced MAOs. Penetrating type, CRP\u2009\u2265\u20090.5\u2009mg/dL, and Alb\u2009<\u20093.8\u2009g/dL at week 24 were identified as independent risk factors (2.39, 1.90, and 2.20, respectively). Even in settings without fecal calprotectin, tight control management based on serum CRP and Alb may help avoid MAOs.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/s41598-020-57508-7", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1045337", 
        "issn": [
          "2045-2322"
        ], 
        "name": "Scientific Reports", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "10"
      }
    ], 
    "keywords": [
      "independent risk factor", 
      "Crohn's disease", 
      "tight control management", 
      "fecal calprotectin", 
      "risk factors", 
      "anti-tumor necrosis factor agents", 
      "serum C-reactive protein", 
      "conventional clinical management", 
      "necrosis factor agents", 
      "major adverse outcomes", 
      "C-reactive protein", 
      "Japanese CD patients", 
      "factor agents", 
      "serum CRP", 
      "CD patients", 
      "week 24", 
      "treatment course", 
      "adverse outcomes", 
      "clinical management", 
      "week 8", 
      "useful biomarker", 
      "better outcomes", 
      "patients", 
      "multivariate analysis", 
      "dl", 
      "disease", 
      "biomarker results", 
      "CRP", 
      "calprotectin", 
      "Western countries", 
      "biomarkers", 
      "weeks", 
      "outcomes", 
      "Alb", 
      "management", 
      "MAO", 
      "tight control", 
      "factors", 
      "association", 
      "albumin", 
      "control management", 
      "Asians", 
      "failure", 
      "agents", 
      "setting", 
      "course", 
      "control", 
      "protein", 
      "types", 
      "countries", 
      "Japan", 
      "analysis", 
      "results"
    ], 
    "name": "Serum C-reactive protein and albumin are useful biomarkers for tight control management of Crohn\u2019s disease in Japan", 
    "pagination": "511", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1124120242"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/s41598-020-57508-7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "31949246"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/s41598-020-57508-7", 
      "https://app.dimensions.ai/details/publication/pub.1124120242"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-10T10:28", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_876.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/s41598-020-57508-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41598-020-57508-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41598-020-57508-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41598-020-57508-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41598-020-57508-7'


 

This table displays all metadata directly associated to this object as RDF triples.

266 TRIPLES      22 PREDICATES      100 URIs      87 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/s41598-020-57508-7 schema:about N005ca238e98345059c2981d110e379da
2 N146d91f234e745158e958fcc8e1bfde1
3 N16140c90b0f04947aceeee4bb5a00098
4 N23cfb1a498614ffda995f2b49eaba783
5 N2d57d23ffd1c4e388f12eb98e9118333
6 N359310d8b9674053abd782f4eafd4eca
7 N3964a4d220ba46ea84a130d1977833f7
8 N5e7ae63022bc4f82817aa9afe0d3faf6
9 N68e0331fd2374dceb325286e2386ab28
10 N943b2773dbfa4d82995ae608ae0030e7
11 Nc0d7855cf9aa4d21ba0e34252dfd521b
12 Nc5c009e4f11b41c791007f2efbea7e6b
13 Nce590a2205ef48c98b2e95582d32100d
14 Ne5ef2f61e744496090376710c3b3c529
15 Nf70a5d646fb9439c9a6a4190e3f261ba
16 Nfa3af5781b3b4395a47c4c1d42a895be
17 anzsrc-for:11
18 anzsrc-for:1103
19 schema:author Ndd51575e0d12478a98e196f1f4d6769f
20 schema:citation sg:pub.10.1007/s00535-013-0798-x
21 sg:pub.10.1007/s00535-018-1439-1
22 sg:pub.10.1038/ajg.2009.545
23 sg:pub.10.1038/ajg.2015.233
24 sg:pub.10.1111/j.1572-0241.2007.01556.x
25 schema:datePublished 2020-01-16
26 schema:datePublishedReg 2020-01-16
27 schema:description Tight control management of Crohn’s disease (CD) based on biomarkers is more effective than conventional clinical management; however, fecal calprotectin is not allowed in Asian and some Western countries. To investigate whether tight control management based on readily available serum biomarkers results in better outcomes, we retrospectively reviewed treatment courses of consecutive Japanese CD patients treated with anti-tumor necrosis factor agents between 2003 and 2018. The association between failure of tight control (C-reactive protein (CRP) ≥ 0.5 mg/dL or albumin (Alb) < 3.8 g/dL at week 8 or 24) and subsequent major adverse outcomes (MAOs; hospitalization related to CD worsening, surgery, and discontinuation due to treatment failure) were analyzed. Among 223 patients followed for >8 weeks, 88 patients experienced MAOs. Multivariate analysis identified penetrating type, CRP ≥ 0.5 mg/dL and Alb < 3.8 g/dL at week 8 as independent risk factors (hazard ratios: 2.16, 2.06, and 2.08, respectively). Among 204 patients followed for >24 weeks, 80 patients experienced MAOs. Penetrating type, CRP ≥ 0.5 mg/dL, and Alb < 3.8 g/dL at week 24 were identified as independent risk factors (2.39, 1.90, and 2.20, respectively). Even in settings without fecal calprotectin, tight control management based on serum CRP and Alb may help avoid MAOs.
28 schema:genre article
29 schema:inLanguage en
30 schema:isAccessibleForFree true
31 schema:isPartOf N6954772aebb54d298b34397e337a2d91
32 Nb7789444a1aa462682eed15161c1249a
33 sg:journal.1045337
34 schema:keywords Alb
35 Asians
36 C-reactive protein
37 CD patients
38 CRP
39 Crohn's disease
40 Japan
41 Japanese CD patients
42 MAO
43 Western countries
44 adverse outcomes
45 agents
46 albumin
47 analysis
48 anti-tumor necrosis factor agents
49 association
50 better outcomes
51 biomarker results
52 biomarkers
53 calprotectin
54 clinical management
55 control
56 control management
57 conventional clinical management
58 countries
59 course
60 disease
61 dl
62 factor agents
63 factors
64 failure
65 fecal calprotectin
66 independent risk factor
67 major adverse outcomes
68 management
69 multivariate analysis
70 necrosis factor agents
71 outcomes
72 patients
73 protein
74 results
75 risk factors
76 serum C-reactive protein
77 serum CRP
78 setting
79 tight control
80 tight control management
81 treatment course
82 types
83 useful biomarker
84 week 24
85 week 8
86 weeks
87 schema:name Serum C-reactive protein and albumin are useful biomarkers for tight control management of Crohn’s disease in Japan
88 schema:pagination 511
89 schema:productId N0fc9bf99948b4615b092fcb1d7009b44
90 Nbd79292814d64e0392041f52a51b3dc4
91 Nd9c5a90e2fc949cfa7999a5777ecbe7c
92 schema:sameAs https://app.dimensions.ai/details/publication/pub.1124120242
93 https://doi.org/10.1038/s41598-020-57508-7
94 schema:sdDatePublished 2022-05-10T10:28
95 schema:sdLicense https://scigraph.springernature.com/explorer/license/
96 schema:sdPublisher N2078a30507b84fcca5faa30efb85d682
97 schema:url https://doi.org/10.1038/s41598-020-57508-7
98 sgo:license sg:explorer/license/
99 sgo:sdDataset articles
100 rdf:type schema:ScholarlyArticle
101 N005ca238e98345059c2981d110e379da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Retrospective Studies
103 rdf:type schema:DefinedTerm
104 N0fc9bf99948b4615b092fcb1d7009b44 schema:name pubmed_id
105 schema:value 31949246
106 rdf:type schema:PropertyValue
107 N146d91f234e745158e958fcc8e1bfde1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Biomarkers
109 rdf:type schema:DefinedTerm
110 N16140c90b0f04947aceeee4bb5a00098 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Tumor Necrosis Factor-alpha
112 rdf:type schema:DefinedTerm
113 N2078a30507b84fcca5faa30efb85d682 schema:name Springer Nature - SN SciGraph project
114 rdf:type schema:Organization
115 N23cfb1a498614ffda995f2b49eaba783 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Female
117 rdf:type schema:DefinedTerm
118 N2d57d23ffd1c4e388f12eb98e9118333 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name C-Reactive Protein
120 rdf:type schema:DefinedTerm
121 N359310d8b9674053abd782f4eafd4eca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Treatment Outcome
123 rdf:type schema:DefinedTerm
124 N3964a4d220ba46ea84a130d1977833f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Young Adult
126 rdf:type schema:DefinedTerm
127 N5e7ae63022bc4f82817aa9afe0d3faf6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Hospitalization
129 rdf:type schema:DefinedTerm
130 N68e0331fd2374dceb325286e2386ab28 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Crohn Disease
132 rdf:type schema:DefinedTerm
133 N6954772aebb54d298b34397e337a2d91 schema:issueNumber 1
134 rdf:type schema:PublicationIssue
135 N7bf8523b7fe54aabac9c2bd648b599c5 rdf:first sg:person.0604532214.34
136 rdf:rest N96629e78bf1f40b5bddf41772bda2356
137 N833159f5839149d3894cfe6873d2089f rdf:first sg:person.01366123207.25
138 rdf:rest rdf:nil
139 N943b2773dbfa4d82995ae608ae0030e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Adalimumab
141 rdf:type schema:DefinedTerm
142 N96629e78bf1f40b5bddf41772bda2356 rdf:first sg:person.012611662635.04
143 rdf:rest Nf94d9ff834dd4b76845d42aaef341153
144 Na1a5a719c1644eb79738d9664529aafc rdf:first sg:person.015335735133.41
145 rdf:rest Ne65f5e7ef9274301b513d301b43a7957
146 Naf71e37b3559461e898d46c2e466635d rdf:first sg:person.01031346114.94
147 rdf:rest Nc42e1a427c0245718267735d695b0b5b
148 Nb7789444a1aa462682eed15161c1249a schema:volumeNumber 10
149 rdf:type schema:PublicationVolume
150 Nbd79292814d64e0392041f52a51b3dc4 schema:name dimensions_id
151 schema:value pub.1124120242
152 rdf:type schema:PropertyValue
153 Nc0d7855cf9aa4d21ba0e34252dfd521b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Japan
155 rdf:type schema:DefinedTerm
156 Nc42e1a427c0245718267735d695b0b5b rdf:first sg:person.01001764110.70
157 rdf:rest N7bf8523b7fe54aabac9c2bd648b599c5
158 Nc5c009e4f11b41c791007f2efbea7e6b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Adult
160 rdf:type schema:DefinedTerm
161 Nce590a2205ef48c98b2e95582d32100d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Humans
163 rdf:type schema:DefinedTerm
164 Nd9c5a90e2fc949cfa7999a5777ecbe7c schema:name doi
165 schema:value 10.1038/s41598-020-57508-7
166 rdf:type schema:PropertyValue
167 Ndd51575e0d12478a98e196f1f4d6769f rdf:first sg:person.01213707714.59
168 rdf:rest Na1a5a719c1644eb79738d9664529aafc
169 Ne5ef2f61e744496090376710c3b3c529 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Infliximab
171 rdf:type schema:DefinedTerm
172 Ne65f5e7ef9274301b513d301b43a7957 rdf:first sg:person.01177630723.05
173 rdf:rest Naf71e37b3559461e898d46c2e466635d
174 Nf251d92bfe9844d5a4757406dde67c28 rdf:first sg:person.01145574514.32
175 rdf:rest N833159f5839149d3894cfe6873d2089f
176 Nf70a5d646fb9439c9a6a4190e3f261ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Serum Albumin
178 rdf:type schema:DefinedTerm
179 Nf94d9ff834dd4b76845d42aaef341153 rdf:first sg:person.013547252522.01
180 rdf:rest Nf251d92bfe9844d5a4757406dde67c28
181 Nfa3af5781b3b4395a47c4c1d42a895be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Male
183 rdf:type schema:DefinedTerm
184 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
185 schema:name Medical and Health Sciences
186 rdf:type schema:DefinedTerm
187 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
188 schema:name Clinical Sciences
189 rdf:type schema:DefinedTerm
190 sg:journal.1045337 schema:issn 2045-2322
191 schema:name Scientific Reports
192 schema:publisher Springer Nature
193 rdf:type schema:Periodical
194 sg:person.01001764110.70 schema:affiliation grid-institutes:grid.69566.3a
195 schema:familyName Kuroha
196 schema:givenName Masatake
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001764110.70
198 rdf:type schema:Person
199 sg:person.01031346114.94 schema:affiliation grid-institutes:grid.69566.3a
200 schema:familyName Moroi
201 schema:givenName Rintaro
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031346114.94
203 rdf:type schema:Person
204 sg:person.01145574514.32 schema:affiliation grid-institutes:grid.69566.3a
205 schema:familyName Kinouchi
206 schema:givenName Yoshitaka
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145574514.32
208 rdf:type schema:Person
209 sg:person.01177630723.05 schema:affiliation grid-institutes:grid.69566.3a
210 schema:familyName Onodera
211 schema:givenName Motoyuki
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177630723.05
213 rdf:type schema:Person
214 sg:person.01213707714.59 schema:affiliation grid-institutes:grid.69566.3a
215 schema:familyName Shiga
216 schema:givenName Hisashi
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213707714.59
218 rdf:type schema:Person
219 sg:person.012611662635.04 schema:affiliation grid-institutes:grid.69566.3a
220 schema:familyName Kakuta
221 schema:givenName Yoichi
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012611662635.04
223 rdf:type schema:Person
224 sg:person.013547252522.01 schema:affiliation grid-institutes:grid.412755.0
225 schema:familyName Endo
226 schema:givenName Katsuya
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013547252522.01
228 rdf:type schema:Person
229 sg:person.01366123207.25 schema:affiliation grid-institutes:grid.69566.3a
230 schema:familyName Masamune
231 schema:givenName Atsushi
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366123207.25
233 rdf:type schema:Person
234 sg:person.015335735133.41 schema:affiliation grid-institutes:grid.69566.3a
235 schema:familyName Abe
236 schema:givenName Izuru
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015335735133.41
238 rdf:type schema:Person
239 sg:person.0604532214.34 schema:affiliation grid-institutes:grid.69566.3a
240 schema:familyName Kanazawa
241 schema:givenName Yoshitake
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604532214.34
243 rdf:type schema:Person
244 sg:pub.10.1007/s00535-013-0798-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1009680601
245 https://doi.org/10.1007/s00535-013-0798-x
246 rdf:type schema:CreativeWork
247 sg:pub.10.1007/s00535-018-1439-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100940665
248 https://doi.org/10.1007/s00535-018-1439-1
249 rdf:type schema:CreativeWork
250 sg:pub.10.1038/ajg.2009.545 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029995757
251 https://doi.org/10.1038/ajg.2009.545
252 rdf:type schema:CreativeWork
253 sg:pub.10.1038/ajg.2015.233 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030438370
254 https://doi.org/10.1038/ajg.2015.233
255 rdf:type schema:CreativeWork
256 sg:pub.10.1111/j.1572-0241.2007.01556.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1027137671
257 https://doi.org/10.1111/j.1572-0241.2007.01556.x
258 rdf:type schema:CreativeWork
259 grid-institutes:grid.412755.0 schema:alternateName Division of Gastroenterology and Hepatology, Tohoku Medical and Pharmaceutical University, Sendai, Japan
260 schema:name Division of Gastroenterology and Hepatology, Tohoku Medical and Pharmaceutical University, Sendai, Japan
261 rdf:type schema:Organization
262 grid-institutes:grid.69566.3a schema:alternateName Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan
263 Health Administration Center, Center for the Advancement of Higher Education, Tohoku University, Sendai, Japan
264 schema:name Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan
265 Health Administration Center, Center for the Advancement of Higher Education, Tohoku University, Sendai, Japan
266 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...